Global Cell Therapy CMO Supply, Demand and Key Producers, 2026-2032
The global Cell Therapy CMO market size is expected to reach $ 4743 million by 2032, rising at a market growth of 6.8% CAGR during the forecast period (2026-2032).
Cell Therapy CMO is an organization that provides professional, large-scale manufacturing outsourcing services to cell therapy drug development companies. The core of this service lies in helping clients transform their laboratory-scale cell preparation processes into industrial-scale production processes that comply with Good Manufacturing Practices (GMP), solving key challenges in the industrialization of cell therapies, such as process development, quality control, and regulatory compliance. Services cover the entire manufacturing chain of autologous and allogeneic cell therapy products, including viral vector production, cell collection and isolation, gene modification, cell expansion and activation, formulation filling, cryopreservation and transportation, and quality control and release testing. Relying on standardized GMP cleanrooms, closed automated culture systems, and a rigorous quality management system, the CMO ensures the stability, safety, and efficacy of cell products across different batches, thereby accelerating the transition of cell therapy from clinical research to commercial application.
The global Cell Therapy CMO market for cell therapy is experiencing rapid growth driven by the proliferation of cell therapy pipelines and the demand for commercialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust GMP systems, and extensive CDMO experience to hold leading positions in the commercial production of autologous CAR-T cells, large-scale lentiviral manufacturing, and closed-loop automated platforms. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across the supply chain, is driving the rapid rise of autologous cell therapy CMOs, general-purpose cell manufacturing, and viral vector outsourcing services, with domestic CMOs quickly gaining a competitive edge globally. The industry as a whole is accelerating its evolution towards fully closed-loop automated production, off-the-shelf cell technologies, and a globalized supply chain.
This report studies the global Cell Therapy CMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy CMO total market, 2021-2032, (USD Million)
Global Cell Therapy CMO total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell Therapy CMO total market, key domestic companies, and share, (USD Million)
Global Cell Therapy CMO revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell Therapy CMO total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell Therapy CMO total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell Therapy CMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc, Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, Made Scientific, AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell Therapy CMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell Therapy CMO Market, By Region:
1. How big is the global Cell Therapy CMO market?
2. What is the demand of the global Cell Therapy CMO market?
3. What is the year over year growth of the global Cell Therapy CMO market?
4. What is the total value of the global Cell Therapy CMO market?
5. Who are the Major Players in the global Cell Therapy CMO market?
6. What are the growth factors driving the market demand?
Cell Therapy CMO is an organization that provides professional, large-scale manufacturing outsourcing services to cell therapy drug development companies. The core of this service lies in helping clients transform their laboratory-scale cell preparation processes into industrial-scale production processes that comply with Good Manufacturing Practices (GMP), solving key challenges in the industrialization of cell therapies, such as process development, quality control, and regulatory compliance. Services cover the entire manufacturing chain of autologous and allogeneic cell therapy products, including viral vector production, cell collection and isolation, gene modification, cell expansion and activation, formulation filling, cryopreservation and transportation, and quality control and release testing. Relying on standardized GMP cleanrooms, closed automated culture systems, and a rigorous quality management system, the CMO ensures the stability, safety, and efficacy of cell products across different batches, thereby accelerating the transition of cell therapy from clinical research to commercial application.
The global Cell Therapy CMO market for cell therapy is experiencing rapid growth driven by the proliferation of cell therapy pipelines and the demand for commercialization. North America and Europe, as mature markets, leverage their leading viral vector technologies, robust GMP systems, and extensive CDMO experience to hold leading positions in the commercial production of autologous CAR-T cells, large-scale lentiviral manufacturing, and closed-loop automated platforms. The Asia-Pacific region has become the fastest-growing and most rapidly expanding sector. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across the supply chain, is driving the rapid rise of autologous cell therapy CMOs, general-purpose cell manufacturing, and viral vector outsourcing services, with domestic CMOs quickly gaining a competitive edge globally. The industry as a whole is accelerating its evolution towards fully closed-loop automated production, off-the-shelf cell technologies, and a globalized supply chain.
This report studies the global Cell Therapy CMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell Therapy CMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Therapy CMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell Therapy CMO total market, 2021-2032, (USD Million)
Global Cell Therapy CMO total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Cell Therapy CMO total market, key domestic companies, and share, (USD Million)
Global Cell Therapy CMO revenue by player, revenue and market share 2021-2026, (USD Million)
Global Cell Therapy CMO total market by Type, CAGR, 2021-2032, (USD Million)
Global Cell Therapy CMO total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Cell Therapy CMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc, Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, Made Scientific, AGC Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Cell Therapy CMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Cell Therapy CMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Open-type CMO
- Closed-type CMO
- Autologous Cell Therapy
- Universal Cell Therapy
- Xenogeneic Cell Therapy
- Immunotherapy CMO
- Stem Cell Therapy CMO
- Somatic Cell Therapy CMO
- Others
- Commercial
- Academic Research
- Others
- Amgen Inc.
- Dendreon Pharmaceuticals LLC.
- Fibrocell Science, Inc
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- Made Scientific
- AGC Biologics
- Pfizer CentreOne
- Samsung Biologics
- Kite Pharma, Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- WuXi AppTec
- Pharmaron
- OBiO
- Exothera
1. How big is the global Cell Therapy CMO market?
2. What is the demand of the global Cell Therapy CMO market?
3. What is the year over year growth of the global Cell Therapy CMO market?
4. What is the total value of the global Cell Therapy CMO market?
5. Who are the Major Players in the global Cell Therapy CMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell Therapy CMO Introduction
1.2 World Cell Therapy CMO Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell Therapy CMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy CMO Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.3 China Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.4 Europe Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.5 Japan Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.6 South Korea Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.8 India Based Company Cell Therapy CMO Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell Therapy CMO Consumption Value (2021-2032)
2.2 World Cell Therapy CMO Consumption Value by Region
2.2.1 World Cell Therapy CMO Consumption Value by Region (2021-2026)
2.2.2 World Cell Therapy CMO Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell Therapy CMO Consumption Value (2021-2032)
2.4 China Cell Therapy CMO Consumption Value (2021-2032)
2.5 Europe Cell Therapy CMO Consumption Value (2021-2032)
2.6 Japan Cell Therapy CMO Consumption Value (2021-2032)
2.7 South Korea Cell Therapy CMO Consumption Value (2021-2032)
2.8 ASEAN Cell Therapy CMO Consumption Value (2021-2032)
2.9 India Cell Therapy CMO Consumption Value (2021-2032)
3 WORLD CELL THERAPY CMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy CMO Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy CMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy CMO in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy CMO in 2025
3.3 Cell Therapy CMO Company Evaluation Quadrant
3.4 Cell Therapy CMO Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy CMO Market: Region Footprint
3.4.2 Cell Therapy CMO Market: Company Product Type Footprint
3.4.3 Cell Therapy CMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy CMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy CMO Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy CMO Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell Therapy CMO Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy CMO Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell Therapy CMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell Therapy CMO Companies and Market Share, 2021-2026
4.3.1 United States Based Cell Therapy CMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy CMO Revenue, (2021-2026)
4.4 China Based Companies Cell Therapy CMO Revenue and Market Share, 2021-2026
4.4.1 China Based Cell Therapy CMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy CMO Revenue, (2021-2026)
4.5 Rest of World Based Cell Therapy CMO Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell Therapy CMO Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell Therapy CMO Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy CMO Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Open-type CMO
5.2.2 Closed-type CMO
5.3 Market Segment by Type
5.3.1 World Cell Therapy CMO Market Size by Type (2021-2026)
5.3.2 World Cell Therapy CMO Market Size by Type (2027-2032)
5.3.3 World Cell Therapy CMO Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL SOURCE
6.1 World Cell Therapy CMO Market Size Overview by Cell Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source
6.2.1 Autologous Cell Therapy
6.2.2 Universal Cell Therapy
6.2.3 Xenogeneic Cell Therapy
6.3 Market Segment by Cell Source
6.3.1 World Cell Therapy CMO Market Size by Cell Source (2021-2026)
6.3.2 World Cell Therapy CMO Market Size by Cell Source (2027-2032)
6.3.3 World Cell Therapy CMO Market Size Market Share by Cell Source (2027-2032)
7 MARKET ANALYSIS BY CELL TYPES
7.1 World Cell Therapy CMO Market Size Overview by Cell Types: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cell Types
7.2.1 Immunotherapy CMO
7.2.2 Stem Cell Therapy CMO
7.2.3 Somatic Cell Therapy CMO
7.2.4 Others
7.3 Market Segment by Cell Types
7.3.1 World Cell Therapy CMO Market Size by Cell Types (2021-2026)
7.3.2 World Cell Therapy CMO Market Size by Cell Types (2027-2032)
7.3.3 World Cell Therapy CMO Market Size Market Share by Cell Types (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell Therapy CMO Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Commercial
8.2.2 Academic Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cell Therapy CMO Market Size by Application (2021-2026)
8.3.2 World Cell Therapy CMO Market Size by Application (2027-2032)
8.3.3 World Cell Therapy CMO Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Amgen Inc.
9.1.1 Amgen Inc. Details
9.1.2 Amgen Inc. Major Business
9.1.3 Amgen Inc. Cell Therapy CMO Product and Services
9.1.4 Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Amgen Inc. Recent Developments/Updates
9.1.6 Amgen Inc. Competitive Strengths & Weaknesses
9.2 Dendreon Pharmaceuticals LLC.
9.2.1 Dendreon Pharmaceuticals LLC. Details
9.2.2 Dendreon Pharmaceuticals LLC. Major Business
9.2.3 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product and Services
9.2.4 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
9.2.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
9.3 Fibrocell Science, Inc
9.3.1 Fibrocell Science, Inc Details
9.3.2 Fibrocell Science, Inc Major Business
9.3.3 Fibrocell Science, Inc Cell Therapy CMO Product and Services
9.3.4 Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Fibrocell Science, Inc Recent Developments/Updates
9.3.6 Fibrocell Science, Inc Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Cell Therapy CMO Product and Services
9.4.4 Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Charles River Laboratories
9.5.1 Charles River Laboratories Details
9.5.2 Charles River Laboratories Major Business
9.5.3 Charles River Laboratories Cell Therapy CMO Product and Services
9.5.4 Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Charles River Laboratories Recent Developments/Updates
9.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.6 Cytiva
9.6.1 Cytiva Details
9.6.2 Cytiva Major Business
9.6.3 Cytiva Cell Therapy CMO Product and Services
9.6.4 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cytiva Recent Developments/Updates
9.6.6 Cytiva Competitive Strengths & Weaknesses
9.7 Catalent Biologics
9.7.1 Catalent Biologics Details
9.7.2 Catalent Biologics Major Business
9.7.3 Catalent Biologics Cell Therapy CMO Product and Services
9.7.4 Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Biologics Recent Developments/Updates
9.7.6 Catalent Biologics Competitive Strengths & Weaknesses
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Details
9.8.2 FUJIFILM Diosynth Biotechnologies Major Business
9.8.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
9.8.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
9.8.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
9.9 Made Scientific
9.9.1 Made Scientific Details
9.9.2 Made Scientific Major Business
9.9.3 Made Scientific Cell Therapy CMO Product and Services
9.9.4 Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Made Scientific Recent Developments/Updates
9.9.6 Made Scientific Competitive Strengths & Weaknesses
9.10 AGC Biologics
9.10.1 AGC Biologics Details
9.10.2 AGC Biologics Major Business
9.10.3 AGC Biologics Cell Therapy CMO Product and Services
9.10.4 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Biologics Recent Developments/Updates
9.10.6 AGC Biologics Competitive Strengths & Weaknesses
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Details
9.11.2 Pfizer CentreOne Major Business
9.11.3 Pfizer CentreOne Cell Therapy CMO Product and Services
9.11.4 Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer CentreOne Recent Developments/Updates
9.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.12 Samsung Biologics
9.12.1 Samsung Biologics Details
9.12.2 Samsung Biologics Major Business
9.12.3 Samsung Biologics Cell Therapy CMO Product and Services
9.12.4 Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Samsung Biologics Recent Developments/Updates
9.12.6 Samsung Biologics Competitive Strengths & Weaknesses
9.13 Kite Pharma, Inc.
9.13.1 Kite Pharma, Inc. Details
9.13.2 Kite Pharma, Inc. Major Business
9.13.3 Kite Pharma, Inc. Cell Therapy CMO Product and Services
9.13.4 Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kite Pharma, Inc. Recent Developments/Updates
9.13.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
9.14 Kolon TissueGene, Inc.
9.14.1 Kolon TissueGene, Inc. Details
9.14.2 Kolon TissueGene, Inc. Major Business
9.14.3 Kolon TissueGene, Inc. Cell Therapy CMO Product and Services
9.14.4 Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kolon TissueGene, Inc. Recent Developments/Updates
9.14.6 Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
9.15 Novartis AG
9.15.1 Novartis AG Details
9.15.2 Novartis AG Major Business
9.15.3 Novartis AG Cell Therapy CMO Product and Services
9.15.4 Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novartis AG Recent Developments/Updates
9.15.6 Novartis AG Competitive Strengths & Weaknesses
9.16 WuXi AppTec
9.16.1 WuXi AppTec Details
9.16.2 WuXi AppTec Major Business
9.16.3 WuXi AppTec Cell Therapy CMO Product and Services
9.16.4 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 WuXi AppTec Recent Developments/Updates
9.16.6 WuXi AppTec Competitive Strengths & Weaknesses
9.17 Pharmaron
9.17.1 Pharmaron Details
9.17.2 Pharmaron Major Business
9.17.3 Pharmaron Cell Therapy CMO Product and Services
9.17.4 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Pharmaron Recent Developments/Updates
9.17.6 Pharmaron Competitive Strengths & Weaknesses
9.18 OBiO
9.18.1 OBiO Details
9.18.2 OBiO Major Business
9.18.3 OBiO Cell Therapy CMO Product and Services
9.18.4 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 OBiO Recent Developments/Updates
9.18.6 OBiO Competitive Strengths & Weaknesses
9.19 Exothera
9.19.1 Exothera Details
9.19.2 Exothera Major Business
9.19.3 Exothera Cell Therapy CMO Product and Services
9.19.4 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Exothera Recent Developments/Updates
9.19.6 Exothera Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell Therapy CMO Industry Chain
10.2 Cell Therapy CMO Upstream Analysis
10.3 Cell Therapy CMO Midstream Analysis
10.4 Cell Therapy CMO Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Cell Therapy CMO Introduction
1.2 World Cell Therapy CMO Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Cell Therapy CMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell Therapy CMO Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.3 China Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.4 Europe Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.5 Japan Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.6 South Korea Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.7 ASEAN Based Company Cell Therapy CMO Revenue (2021-2032)
1.3.8 India Based Company Cell Therapy CMO Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell Therapy CMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell Therapy CMO Consumption Value (2021-2032)
2.2 World Cell Therapy CMO Consumption Value by Region
2.2.1 World Cell Therapy CMO Consumption Value by Region (2021-2026)
2.2.2 World Cell Therapy CMO Consumption Value Forecast by Region (2027-2032)
2.3 United States Cell Therapy CMO Consumption Value (2021-2032)
2.4 China Cell Therapy CMO Consumption Value (2021-2032)
2.5 Europe Cell Therapy CMO Consumption Value (2021-2032)
2.6 Japan Cell Therapy CMO Consumption Value (2021-2032)
2.7 South Korea Cell Therapy CMO Consumption Value (2021-2032)
2.8 ASEAN Cell Therapy CMO Consumption Value (2021-2032)
2.9 India Cell Therapy CMO Consumption Value (2021-2032)
3 WORLD CELL THERAPY CMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell Therapy CMO Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell Therapy CMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell Therapy CMO in 2025
3.2.3 Global Concentration Ratios (CR8) for Cell Therapy CMO in 2025
3.3 Cell Therapy CMO Company Evaluation Quadrant
3.4 Cell Therapy CMO Market: Overall Company Footprint Analysis
3.4.1 Cell Therapy CMO Market: Region Footprint
3.4.2 Cell Therapy CMO Market: Company Product Type Footprint
3.4.3 Cell Therapy CMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell Therapy CMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell Therapy CMO Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Cell Therapy CMO Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Cell Therapy CMO Consumption Value Comparison
4.2.1 United States VS China: Cell Therapy CMO Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Cell Therapy CMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Cell Therapy CMO Companies and Market Share, 2021-2026
4.3.1 United States Based Cell Therapy CMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell Therapy CMO Revenue, (2021-2026)
4.4 China Based Companies Cell Therapy CMO Revenue and Market Share, 2021-2026
4.4.1 China Based Cell Therapy CMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell Therapy CMO Revenue, (2021-2026)
4.5 Rest of World Based Cell Therapy CMO Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Cell Therapy CMO Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Cell Therapy CMO Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell Therapy CMO Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Open-type CMO
5.2.2 Closed-type CMO
5.3 Market Segment by Type
5.3.1 World Cell Therapy CMO Market Size by Type (2021-2026)
5.3.2 World Cell Therapy CMO Market Size by Type (2027-2032)
5.3.3 World Cell Therapy CMO Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CELL SOURCE
6.1 World Cell Therapy CMO Market Size Overview by Cell Source: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source
6.2.1 Autologous Cell Therapy
6.2.2 Universal Cell Therapy
6.2.3 Xenogeneic Cell Therapy
6.3 Market Segment by Cell Source
6.3.1 World Cell Therapy CMO Market Size by Cell Source (2021-2026)
6.3.2 World Cell Therapy CMO Market Size by Cell Source (2027-2032)
6.3.3 World Cell Therapy CMO Market Size Market Share by Cell Source (2027-2032)
7 MARKET ANALYSIS BY CELL TYPES
7.1 World Cell Therapy CMO Market Size Overview by Cell Types: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Cell Types
7.2.1 Immunotherapy CMO
7.2.2 Stem Cell Therapy CMO
7.2.3 Somatic Cell Therapy CMO
7.2.4 Others
7.3 Market Segment by Cell Types
7.3.1 World Cell Therapy CMO Market Size by Cell Types (2021-2026)
7.3.2 World Cell Therapy CMO Market Size by Cell Types (2027-2032)
7.3.3 World Cell Therapy CMO Market Size Market Share by Cell Types (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Cell Therapy CMO Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Commercial
8.2.2 Academic Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Cell Therapy CMO Market Size by Application (2021-2026)
8.3.2 World Cell Therapy CMO Market Size by Application (2027-2032)
8.3.3 World Cell Therapy CMO Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Amgen Inc.
9.1.1 Amgen Inc. Details
9.1.2 Amgen Inc. Major Business
9.1.3 Amgen Inc. Cell Therapy CMO Product and Services
9.1.4 Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Amgen Inc. Recent Developments/Updates
9.1.6 Amgen Inc. Competitive Strengths & Weaknesses
9.2 Dendreon Pharmaceuticals LLC.
9.2.1 Dendreon Pharmaceuticals LLC. Details
9.2.2 Dendreon Pharmaceuticals LLC. Major Business
9.2.3 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product and Services
9.2.4 Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
9.2.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
9.3 Fibrocell Science, Inc
9.3.1 Fibrocell Science, Inc Details
9.3.2 Fibrocell Science, Inc Major Business
9.3.3 Fibrocell Science, Inc Cell Therapy CMO Product and Services
9.3.4 Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Fibrocell Science, Inc Recent Developments/Updates
9.3.6 Fibrocell Science, Inc Competitive Strengths & Weaknesses
9.4 Lonza
9.4.1 Lonza Details
9.4.2 Lonza Major Business
9.4.3 Lonza Cell Therapy CMO Product and Services
9.4.4 Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Lonza Recent Developments/Updates
9.4.6 Lonza Competitive Strengths & Weaknesses
9.5 Charles River Laboratories
9.5.1 Charles River Laboratories Details
9.5.2 Charles River Laboratories Major Business
9.5.3 Charles River Laboratories Cell Therapy CMO Product and Services
9.5.4 Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Charles River Laboratories Recent Developments/Updates
9.5.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.6 Cytiva
9.6.1 Cytiva Details
9.6.2 Cytiva Major Business
9.6.3 Cytiva Cell Therapy CMO Product and Services
9.6.4 Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Cytiva Recent Developments/Updates
9.6.6 Cytiva Competitive Strengths & Weaknesses
9.7 Catalent Biologics
9.7.1 Catalent Biologics Details
9.7.2 Catalent Biologics Major Business
9.7.3 Catalent Biologics Cell Therapy CMO Product and Services
9.7.4 Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Catalent Biologics Recent Developments/Updates
9.7.6 Catalent Biologics Competitive Strengths & Weaknesses
9.8 FUJIFILM Diosynth Biotechnologies
9.8.1 FUJIFILM Diosynth Biotechnologies Details
9.8.2 FUJIFILM Diosynth Biotechnologies Major Business
9.8.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
9.8.4 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
9.8.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
9.9 Made Scientific
9.9.1 Made Scientific Details
9.9.2 Made Scientific Major Business
9.9.3 Made Scientific Cell Therapy CMO Product and Services
9.9.4 Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Made Scientific Recent Developments/Updates
9.9.6 Made Scientific Competitive Strengths & Weaknesses
9.10 AGC Biologics
9.10.1 AGC Biologics Details
9.10.2 AGC Biologics Major Business
9.10.3 AGC Biologics Cell Therapy CMO Product and Services
9.10.4 AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AGC Biologics Recent Developments/Updates
9.10.6 AGC Biologics Competitive Strengths & Weaknesses
9.11 Pfizer CentreOne
9.11.1 Pfizer CentreOne Details
9.11.2 Pfizer CentreOne Major Business
9.11.3 Pfizer CentreOne Cell Therapy CMO Product and Services
9.11.4 Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Pfizer CentreOne Recent Developments/Updates
9.11.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.12 Samsung Biologics
9.12.1 Samsung Biologics Details
9.12.2 Samsung Biologics Major Business
9.12.3 Samsung Biologics Cell Therapy CMO Product and Services
9.12.4 Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Samsung Biologics Recent Developments/Updates
9.12.6 Samsung Biologics Competitive Strengths & Weaknesses
9.13 Kite Pharma, Inc.
9.13.1 Kite Pharma, Inc. Details
9.13.2 Kite Pharma, Inc. Major Business
9.13.3 Kite Pharma, Inc. Cell Therapy CMO Product and Services
9.13.4 Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Kite Pharma, Inc. Recent Developments/Updates
9.13.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
9.14 Kolon TissueGene, Inc.
9.14.1 Kolon TissueGene, Inc. Details
9.14.2 Kolon TissueGene, Inc. Major Business
9.14.3 Kolon TissueGene, Inc. Cell Therapy CMO Product and Services
9.14.4 Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Kolon TissueGene, Inc. Recent Developments/Updates
9.14.6 Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
9.15 Novartis AG
9.15.1 Novartis AG Details
9.15.2 Novartis AG Major Business
9.15.3 Novartis AG Cell Therapy CMO Product and Services
9.15.4 Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Novartis AG Recent Developments/Updates
9.15.6 Novartis AG Competitive Strengths & Weaknesses
9.16 WuXi AppTec
9.16.1 WuXi AppTec Details
9.16.2 WuXi AppTec Major Business
9.16.3 WuXi AppTec Cell Therapy CMO Product and Services
9.16.4 WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 WuXi AppTec Recent Developments/Updates
9.16.6 WuXi AppTec Competitive Strengths & Weaknesses
9.17 Pharmaron
9.17.1 Pharmaron Details
9.17.2 Pharmaron Major Business
9.17.3 Pharmaron Cell Therapy CMO Product and Services
9.17.4 Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Pharmaron Recent Developments/Updates
9.17.6 Pharmaron Competitive Strengths & Weaknesses
9.18 OBiO
9.18.1 OBiO Details
9.18.2 OBiO Major Business
9.18.3 OBiO Cell Therapy CMO Product and Services
9.18.4 OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 OBiO Recent Developments/Updates
9.18.6 OBiO Competitive Strengths & Weaknesses
9.19 Exothera
9.19.1 Exothera Details
9.19.2 Exothera Major Business
9.19.3 Exothera Cell Therapy CMO Product and Services
9.19.4 Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Exothera Recent Developments/Updates
9.19.6 Exothera Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Cell Therapy CMO Industry Chain
10.2 Cell Therapy CMO Upstream Analysis
10.3 Cell Therapy CMO Midstream Analysis
10.4 Cell Therapy CMO Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Cell Therapy CMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy CMO Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy CMO Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy CMO Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell Therapy CMO Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy CMO Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell Therapy CMO Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell Therapy CMO Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell Therapy CMO Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy CMO Players in 2025
Table 12. World Cell Therapy CMO Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell Therapy CMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy CMO Players
Table 15. Cell Therapy CMO Market: Company Product Type Footprint
Table 16. Cell Therapy CMO Market: Company Product Application Footprint
Table 17. Cell Therapy CMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy CMO Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell Therapy CMO Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell Therapy CMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy CMO Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 23. China Based Cell Therapy CMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy CMO Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell Therapy CMO Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell Therapy CMO Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 29. World Cell Therapy CMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell Therapy CMO Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell Therapy CMO Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell Therapy CMO Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell Therapy CMO Market Size Value by Cell Source (2021-2026) & (USD Million)
Table 34. World Cell Therapy CMO Market Size by Cell Source (2027-2032) & (USD Million)
Table 35. World Cell Therapy CMO Market Size by Cell Types, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell Therapy CMO Market Size Value by Cell Types (2021-2026) & (USD Million)
Table 37. World Cell Therapy CMO Market Size by Cell Types (2027-2032) & (USD Million)
Table 38. World Cell Therapy CMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell Therapy CMO Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell Therapy CMO Market Size by Application (2027-2032) & (USD Million)
Table 41. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Amgen Inc. Major Business
Table 43. Amgen Inc. Cell Therapy CMO Product and Services
Table 44. Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Amgen Inc. Recent Developments/Updates
Table 46. Amgen Inc. Competitive Strengths & Weaknesses
Table 47. Dendreon Pharmaceuticals LLC. Basic Information, Manufacturing Base and Competitors
Table 48. Dendreon Pharmaceuticals LLC. Major Business
Table 49. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product and Services
Table 50. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
Table 52. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
Table 53. Fibrocell Science, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Fibrocell Science, Inc Major Business
Table 55. Fibrocell Science, Inc Cell Therapy CMO Product and Services
Table 56. Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Fibrocell Science, Inc Recent Developments/Updates
Table 58. Fibrocell Science, Inc Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Cell Therapy CMO Product and Services
Table 62. Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Charles River Laboratories Major Business
Table 67. Charles River Laboratories Cell Therapy CMO Product and Services
Table 68. Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Charles River Laboratories Recent Developments/Updates
Table 70. Charles River Laboratories Competitive Strengths & Weaknesses
Table 71. Cytiva Basic Information, Manufacturing Base and Competitors
Table 72. Cytiva Major Business
Table 73. Cytiva Cell Therapy CMO Product and Services
Table 74. Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cytiva Recent Developments/Updates
Table 76. Cytiva Competitive Strengths & Weaknesses
Table 77. Catalent Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Biologics Major Business
Table 79. Catalent Biologics Cell Therapy CMO Product and Services
Table 80. Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Biologics Recent Developments/Updates
Table 82. Catalent Biologics Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Made Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Made Scientific Major Business
Table 91. Made Scientific Cell Therapy CMO Product and Services
Table 92. Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Made Scientific Recent Developments/Updates
Table 94. Made Scientific Competitive Strengths & Weaknesses
Table 95. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 96. AGC Biologics Major Business
Table 97. AGC Biologics Cell Therapy CMO Product and Services
Table 98. AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Biologics Recent Developments/Updates
Table 100. AGC Biologics Competitive Strengths & Weaknesses
Table 101. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 102. Pfizer CentreOne Major Business
Table 103. Pfizer CentreOne Cell Therapy CMO Product and Services
Table 104. Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pfizer CentreOne Recent Developments/Updates
Table 106. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 107. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 108. Samsung Biologics Major Business
Table 109. Samsung Biologics Cell Therapy CMO Product and Services
Table 110. Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Samsung Biologics Recent Developments/Updates
Table 112. Samsung Biologics Competitive Strengths & Weaknesses
Table 113. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Kite Pharma, Inc. Major Business
Table 115. Kite Pharma, Inc. Cell Therapy CMO Product and Services
Table 116. Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kite Pharma, Inc. Recent Developments/Updates
Table 118. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 119. Kolon TissueGene, Inc. Basic Information, Manufacturing Base and Competitors
Table 120. Kolon TissueGene, Inc. Major Business
Table 121. Kolon TissueGene, Inc. Cell Therapy CMO Product and Services
Table 122. Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kolon TissueGene, Inc. Recent Developments/Updates
Table 124. Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
Table 125. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 126. Novartis AG Major Business
Table 127. Novartis AG Cell Therapy CMO Product and Services
Table 128. Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novartis AG Recent Developments/Updates
Table 130. Novartis AG Competitive Strengths & Weaknesses
Table 131. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 132. WuXi AppTec Major Business
Table 133. WuXi AppTec Cell Therapy CMO Product and Services
Table 134. WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. WuXi AppTec Recent Developments/Updates
Table 136. WuXi AppTec Competitive Strengths & Weaknesses
Table 137. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 138. Pharmaron Major Business
Table 139. Pharmaron Cell Therapy CMO Product and Services
Table 140. Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Pharmaron Recent Developments/Updates
Table 142. Pharmaron Competitive Strengths & Weaknesses
Table 143. OBiO Basic Information, Manufacturing Base and Competitors
Table 144. OBiO Major Business
Table 145. OBiO Cell Therapy CMO Product and Services
Table 146. OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. OBiO Recent Developments/Updates
Table 148. OBiO Competitive Strengths & Weaknesses
Table 149. Exothera Basic Information, Manufacturing Base and Competitors
Table 150. Exothera Major Business
Table 151. Exothera Cell Therapy CMO Product and Services
Table 152. Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Exothera Recent Developments/Updates
Table 154. Exothera Competitive Strengths & Weaknesses
Table 155. Global Key Players of Cell Therapy CMO Upstream (Raw Materials)
Table 156. Global Cell Therapy CMO Typical Customers
Table 1. World Cell Therapy CMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Cell Therapy CMO Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Cell Therapy CMO Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Cell Therapy CMO Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Cell Therapy CMO Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell Therapy CMO Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Cell Therapy CMO Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Cell Therapy CMO Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Cell Therapy CMO Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Cell Therapy CMO Players in 2025
Table 12. World Cell Therapy CMO Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Cell Therapy CMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell Therapy CMO Players
Table 15. Cell Therapy CMO Market: Company Product Type Footprint
Table 16. Cell Therapy CMO Market: Company Product Application Footprint
Table 17. Cell Therapy CMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell Therapy CMO Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Cell Therapy CMO Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Cell Therapy CMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell Therapy CMO Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 23. China Based Cell Therapy CMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell Therapy CMO Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 26. Rest of World Based Cell Therapy CMO Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Cell Therapy CMO Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Cell Therapy CMO Revenue Market Share (2021-2026)
Table 29. World Cell Therapy CMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Cell Therapy CMO Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Cell Therapy CMO Market Size by Type (2027-2032) & (USD Million)
Table 32. World Cell Therapy CMO Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Table 33. World Cell Therapy CMO Market Size Value by Cell Source (2021-2026) & (USD Million)
Table 34. World Cell Therapy CMO Market Size by Cell Source (2027-2032) & (USD Million)
Table 35. World Cell Therapy CMO Market Size by Cell Types, (USD Million), 2021 & 2025 & 2032
Table 36. World Cell Therapy CMO Market Size Value by Cell Types (2021-2026) & (USD Million)
Table 37. World Cell Therapy CMO Market Size by Cell Types (2027-2032) & (USD Million)
Table 38. World Cell Therapy CMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Cell Therapy CMO Market Size by Application (2021-2026) & (USD Million)
Table 40. World Cell Therapy CMO Market Size by Application (2027-2032) & (USD Million)
Table 41. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 42. Amgen Inc. Major Business
Table 43. Amgen Inc. Cell Therapy CMO Product and Services
Table 44. Amgen Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Amgen Inc. Recent Developments/Updates
Table 46. Amgen Inc. Competitive Strengths & Weaknesses
Table 47. Dendreon Pharmaceuticals LLC. Basic Information, Manufacturing Base and Competitors
Table 48. Dendreon Pharmaceuticals LLC. Major Business
Table 49. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Product and Services
Table 50. Dendreon Pharmaceuticals LLC. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
Table 52. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
Table 53. Fibrocell Science, Inc Basic Information, Manufacturing Base and Competitors
Table 54. Fibrocell Science, Inc Major Business
Table 55. Fibrocell Science, Inc Cell Therapy CMO Product and Services
Table 56. Fibrocell Science, Inc Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Fibrocell Science, Inc Recent Developments/Updates
Table 58. Fibrocell Science, Inc Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Manufacturing Base and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Cell Therapy CMO Product and Services
Table 62. Lonza Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 66. Charles River Laboratories Major Business
Table 67. Charles River Laboratories Cell Therapy CMO Product and Services
Table 68. Charles River Laboratories Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Charles River Laboratories Recent Developments/Updates
Table 70. Charles River Laboratories Competitive Strengths & Weaknesses
Table 71. Cytiva Basic Information, Manufacturing Base and Competitors
Table 72. Cytiva Major Business
Table 73. Cytiva Cell Therapy CMO Product and Services
Table 74. Cytiva Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Cytiva Recent Developments/Updates
Table 76. Cytiva Competitive Strengths & Weaknesses
Table 77. Catalent Biologics Basic Information, Manufacturing Base and Competitors
Table 78. Catalent Biologics Major Business
Table 79. Catalent Biologics Cell Therapy CMO Product and Services
Table 80. Catalent Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Catalent Biologics Recent Developments/Updates
Table 82. Catalent Biologics Competitive Strengths & Weaknesses
Table 83. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. FUJIFILM Diosynth Biotechnologies Major Business
Table 85. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product and Services
Table 86. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 88. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 89. Made Scientific Basic Information, Manufacturing Base and Competitors
Table 90. Made Scientific Major Business
Table 91. Made Scientific Cell Therapy CMO Product and Services
Table 92. Made Scientific Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Made Scientific Recent Developments/Updates
Table 94. Made Scientific Competitive Strengths & Weaknesses
Table 95. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 96. AGC Biologics Major Business
Table 97. AGC Biologics Cell Therapy CMO Product and Services
Table 98. AGC Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AGC Biologics Recent Developments/Updates
Table 100. AGC Biologics Competitive Strengths & Weaknesses
Table 101. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 102. Pfizer CentreOne Major Business
Table 103. Pfizer CentreOne Cell Therapy CMO Product and Services
Table 104. Pfizer CentreOne Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Pfizer CentreOne Recent Developments/Updates
Table 106. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 107. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 108. Samsung Biologics Major Business
Table 109. Samsung Biologics Cell Therapy CMO Product and Services
Table 110. Samsung Biologics Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Samsung Biologics Recent Developments/Updates
Table 112. Samsung Biologics Competitive Strengths & Weaknesses
Table 113. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 114. Kite Pharma, Inc. Major Business
Table 115. Kite Pharma, Inc. Cell Therapy CMO Product and Services
Table 116. Kite Pharma, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Kite Pharma, Inc. Recent Developments/Updates
Table 118. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 119. Kolon TissueGene, Inc. Basic Information, Manufacturing Base and Competitors
Table 120. Kolon TissueGene, Inc. Major Business
Table 121. Kolon TissueGene, Inc. Cell Therapy CMO Product and Services
Table 122. Kolon TissueGene, Inc. Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Kolon TissueGene, Inc. Recent Developments/Updates
Table 124. Kolon TissueGene, Inc. Competitive Strengths & Weaknesses
Table 125. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 126. Novartis AG Major Business
Table 127. Novartis AG Cell Therapy CMO Product and Services
Table 128. Novartis AG Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Novartis AG Recent Developments/Updates
Table 130. Novartis AG Competitive Strengths & Weaknesses
Table 131. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 132. WuXi AppTec Major Business
Table 133. WuXi AppTec Cell Therapy CMO Product and Services
Table 134. WuXi AppTec Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. WuXi AppTec Recent Developments/Updates
Table 136. WuXi AppTec Competitive Strengths & Weaknesses
Table 137. Pharmaron Basic Information, Manufacturing Base and Competitors
Table 138. Pharmaron Major Business
Table 139. Pharmaron Cell Therapy CMO Product and Services
Table 140. Pharmaron Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Pharmaron Recent Developments/Updates
Table 142. Pharmaron Competitive Strengths & Weaknesses
Table 143. OBiO Basic Information, Manufacturing Base and Competitors
Table 144. OBiO Major Business
Table 145. OBiO Cell Therapy CMO Product and Services
Table 146. OBiO Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. OBiO Recent Developments/Updates
Table 148. OBiO Competitive Strengths & Weaknesses
Table 149. Exothera Basic Information, Manufacturing Base and Competitors
Table 150. Exothera Major Business
Table 151. Exothera Cell Therapy CMO Product and Services
Table 152. Exothera Cell Therapy CMO Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Exothera Recent Developments/Updates
Table 154. Exothera Competitive Strengths & Weaknesses
Table 155. Global Key Players of Cell Therapy CMO Upstream (Raw Materials)
Table 156. Global Cell Therapy CMO Typical Customers
LIST OF FIGURES
Figure 1. Cell Therapy CMO Picture
Figure 2. World Cell Therapy CMO Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell Therapy CMO Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell Therapy CMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell Therapy CMO Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 13. Cell Therapy CMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell Therapy CMO Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy CMO by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CMO Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CMO Markets in 2025
Figure 27. United States VS China: Cell Therapy CMO Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell Therapy CMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell Therapy CMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell Therapy CMO Market Size Market Share by Type in 2025
Figure 31. Open-type CMO
Figure 32. Closed-type CMO
Figure 33. World Cell Therapy CMO Market Size Market Share by Type (2021-2032)
Figure 34. World Cell Therapy CMO Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 35. World Cell Therapy CMO Market Size Market Share by Cell Source in 2025
Figure 36. Autologous Cell Therapy
Figure 37. Universal Cell Therapy
Figure 38. Xenogeneic Cell Therapy
Figure 39. World Cell Therapy CMO Market Size Market Share by Cell Source (2021-2032)
Figure 40. World Cell Therapy CMO Market Size by Cell Types, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cell Therapy CMO Market Size Market Share by Cell Types in 2025
Figure 42. Immunotherapy CMO
Figure 43. Stem Cell Therapy CMO
Figure 44. Somatic Cell Therapy CMO
Figure 45. Others
Figure 46. World Cell Therapy CMO Market Size Market Share by Cell Types (2021-2032)
Figure 47. World Cell Therapy CMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Cell Therapy CMO Market Size Market Share by Application in 2025
Figure 49. Commercial
Figure 50. Academic Research
Figure 51. Others
Figure 52. World Cell Therapy CMO Market Size Market Share by Application (2021-2032)
Figure 53. Cell Therapy CMO Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Cell Therapy CMO Picture
Figure 2. World Cell Therapy CMO Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Cell Therapy CMO Total Revenue (2021-2032) & (USD Million)
Figure 4. World Cell Therapy CMO Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Cell Therapy CMO Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Cell Therapy CMO Revenue (2021-2032) & (USD Million)
Figure 13. Cell Therapy CMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 16. World Cell Therapy CMO Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 18. China Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 23. India Cell Therapy CMO Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Cell Therapy CMO by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell Therapy CMO Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell Therapy CMO Markets in 2025
Figure 27. United States VS China: Cell Therapy CMO Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Cell Therapy CMO Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Cell Therapy CMO Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Cell Therapy CMO Market Size Market Share by Type in 2025
Figure 31. Open-type CMO
Figure 32. Closed-type CMO
Figure 33. World Cell Therapy CMO Market Size Market Share by Type (2021-2032)
Figure 34. World Cell Therapy CMO Market Size by Cell Source, (USD Million), 2021 & 2025 & 2032
Figure 35. World Cell Therapy CMO Market Size Market Share by Cell Source in 2025
Figure 36. Autologous Cell Therapy
Figure 37. Universal Cell Therapy
Figure 38. Xenogeneic Cell Therapy
Figure 39. World Cell Therapy CMO Market Size Market Share by Cell Source (2021-2032)
Figure 40. World Cell Therapy CMO Market Size by Cell Types, (USD Million), 2021 & 2025 & 2032
Figure 41. World Cell Therapy CMO Market Size Market Share by Cell Types in 2025
Figure 42. Immunotherapy CMO
Figure 43. Stem Cell Therapy CMO
Figure 44. Somatic Cell Therapy CMO
Figure 45. Others
Figure 46. World Cell Therapy CMO Market Size Market Share by Cell Types (2021-2032)
Figure 47. World Cell Therapy CMO Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Cell Therapy CMO Market Size Market Share by Application in 2025
Figure 49. Commercial
Figure 50. Academic Research
Figure 51. Others
Figure 52. World Cell Therapy CMO Market Size Market Share by Application (2021-2032)
Figure 53. Cell Therapy CMO Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
